Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

The detection and prevention of physiological changes in a rat model of early stage Alzheimer's disease

FY 2013-14

Summary
Alzheimer's disease (AD) is a debilitating disorder that degrades the quality of life for the patient and caregiver. It is characterized by the progressive degeneration of brain tissue and a decline of cognitive functions such as memory. Studying the initial changes in AD brains is essential because it will provide new strategies for treatments specifically designed to halt or reverse the progression of AD. One of the earliest features of the disease is the aggregation of a protein called tau in a specific brain region, the entorhinal cortex (EC). However, the mechanisms by which the pathological changes of the EC causes problems in early-stage AD are not well understood. Memory emerges from coordinated activities of groups of brain cells; therefore, tau aggregation in the EC may disrupt the activities of brain cells, and in turn cause memory problems. To test this idea, I propose to examine how accumulation of tau in the EC alters the brain activity patterns while animals form and express memory. Next, I plan to determine whether inhibiting tau accumulation, which is a proposed treatment for AD, will recover normal activity of neurons. If successful, these studies will be the first to show how abnormal tau accumulation in the EC changes the way that brain cells process information to form a memory. It will also test a potential to use tau accumulation inhibitors to prevent the progression of very early stage AD. This will significantly improve our understanding on the biological machinery that is responsible for the early sign of cognitive decline in AD, thereby providing a new strategy for the development of treatments for this devastating condition.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
307777
Name
Tanninen Stephanie
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The detection and prevention of physiological changes in a rat model of early stage Alzheimer's disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Entorhinal Cortex; Hippocampus; Local Field Potential Activity; Memory; Neural Network; Single Neuron Activity; Tau
Abstract
Alzheimer's disease (AD) is a debilitating disorder that degrades the quality of life for the patient and caregiver. It is characterized by the progressive degeneration of brain tissue and a decline of cognitive functions such as memory. Studying the initial changes in AD brains is essential because it will provide new strategies for treatments specifically designed to halt or reverse the progression of AD. One of the earliest features of the disease is the aggregation of a protein called tau in a specific brain region, the entorhinal cortex (EC). However, the mechanisms by which the pathological changes of the EC causes problems in early-stage AD are not well understood. Memory emerges from coordinated activities of groups of brain cells; therefore, tau aggregation in the EC may disrupt the activities of brain cells, and in turn cause memory problems. To test this idea, I propose to examine how accumulation of tau in the EC alters the brain activity patterns while animals form and express memory. Next, I plan to determine whether inhibiting tau accumulation, which is a proposed treatment for AD, will recover normal activity of neurons. If successful, these studies will be the first to show how abnormal tau accumulation in the EC changes the way that brain cells process information to form a memory. It will also test a potential to use tau accumulation inhibitors to prevent the progression of very early stage AD. This will significantly improve our understanding on the biological machinery that is responsible for the early sign of cognitive decline in AD, thereby providing a new strategy for the development of treatments for this devastating condition.
Competitiondate
201310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tanninen, Stephanie
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~